-transparent.png){kind=logo}
BACKGROUND The role of renal transplantation as treatment for end-stage sickle cell nephropathy (SCN) has not been well established. METHODS We performed a comparative investigation of patient and allograft outcomes among age-matched African-American kidney transplant recipients with ESRD as a result of SCN (n=82) and all other causes (Other-ESRD, n=22,565). RESULTS The incidence of delayed graft function and predischarge acute rejection in SCN group (24% and 26%) was similar to that observed in the Other-ESRD group (29% and 27%). The mean discharge serum creatinine (SCr) was 2.7 (+/-2.5) mg/dl in the SCN recipients compared to 3.0 (+/-2.5) mg/dl in the Other-ESRD recipients (P=0.42). There was no difference in the 1-year cadaveric graft survival (SCN: 78% vs. Other-ESRD: 77%), and the multivariable adjusted 1-year risk of graft loss indicated no significant effect of SCN (relative risk [RR]=1.39, P=0.149). However, the 3-year cadaveric graft survival tended to be lower in the SCN group (48% vs. 60%, P=0.055) and their adjusted 3-year risk of graft loss was significantly greater (RR= 1.60, P=0.003). There was a trend toward improved survival in the SCN transplant recipients compared to their dialysis-treated, wait-listed counterparts (RR=0.14, P=0.056). In comparison to the Other-ESRD (RR=1.00), the adjusted mortality risk in the SCN group was higher both at 1 year (RR=2.95, P=0.001) and at 3 years (RR=2.82, P=0.0001) after renal transplantation. CONCLUSIONS The short-term renal allograft result in recipients with end-stage SCN was similar to that obtained in other causes of ESRD, but the long-term outcome was comparatively diminished. There was a trend toward better patient survival with renal transplantation relative to dialysis in end-stage SCN.
A O Ojo, and
T C Govaerts, and
R L Schmouder, and
A B Leichtman, and
S F Leavey, and
R A Wolfe, and
P J Held, and
F K Port, and
L Y Agodoa
September 1994,
Transplantation,
A O Ojo, and
T C Govaerts, and
R L Schmouder, and
A B Leichtman, and
S F Leavey, and
R A Wolfe, and
P J Held, and
F K Port, and
L Y Agodoa
December 1979,
The West Indian medical journal,
A O Ojo, and
T C Govaerts, and
R L Schmouder, and
A B Leichtman, and
S F Leavey, and
R A Wolfe, and
P J Held, and
F K Port, and
L Y Agodoa
March 1995,
Transplantation,
A O Ojo, and
T C Govaerts, and
R L Schmouder, and
A B Leichtman, and
S F Leavey, and
R A Wolfe, and
P J Held, and
F K Port, and
L Y Agodoa
March 1993,
The Journal of the Association of Physicians of India,
A O Ojo, and
T C Govaerts, and
R L Schmouder, and
A B Leichtman, and
S F Leavey, and
R A Wolfe, and
P J Held, and
F K Port, and
L Y Agodoa
November 1981,
JAMA,
A O Ojo, and
T C Govaerts, and
R L Schmouder, and
A B Leichtman, and
S F Leavey, and
R A Wolfe, and
P J Held, and
F K Port, and
L Y Agodoa
March 2004,
Transplantation,
A O Ojo, and
T C Govaerts, and
R L Schmouder, and
A B Leichtman, and
S F Leavey, and
R A Wolfe, and
P J Held, and
F K Port, and
L Y Agodoa
January 2005,
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
A O Ojo, and
T C Govaerts, and
R L Schmouder, and
A B Leichtman, and
S F Leavey, and
R A Wolfe, and
P J Held, and
F K Port, and
L Y Agodoa
July 2002,
Clinical nephrology,
A O Ojo, and
T C Govaerts, and
R L Schmouder, and
A B Leichtman, and
S F Leavey, and
R A Wolfe, and
P J Held, and
F K Port, and
L Y Agodoa
October 1992,
Transplantation proceedings,
A O Ojo, and
T C Govaerts, and
R L Schmouder, and
A B Leichtman, and
S F Leavey, and
R A Wolfe, and
P J Held, and
F K Port, and
L Y Agodoa
January 1980,
Acta medica Scandinavica. Supplementum,
